Artificial intelligence is no longer a peripheral experiment in the pharmaceutical sector; as industry leaders prepare for CPHI 2026, the…
Read More
FDA Approves Cosette Pharmaceuticals Evoxac Oral Solution for Sjögren’s Disease Dry Mouth
Cosette Pharmaceuticals has secured a significant regulatory milestone with the United States Food and Drug Administration (FDA) granting approval for…
Read More
The Hidden Costs of Supplier Sprawl: Why Pharmaceutical Supply Chains Are Moving Toward Consolidation
For decades, the standard playbook for pharmaceutical procurement departments was built on the premise of diversification. As companies launched new…
Read More
AbbVie and McLaren Accelerate Into a Multi-Year Partnership as Big Pharma Seeks Global Visibility Through Elite Motorsport
Biopharmaceutical giant AbbVie has formally accelerated its strategic push into global sports marketing by announcing a multi-year partnership with the…
Read More
Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…
Read More
INmune Bio and Quantum Computing Inc. Join Forces in Milestone Partnership to Accelerate Drug Discovery for XPro Using Advanced Quantum Technology
Biotechnology innovator INmune Bio has entered into a landmark strategic partnership with Quantum Computing Inc. (QCi), marking QCi’s first-ever commercial…
Read More
FDA Unveils Rare Disease Framework Initiative to Accelerate Novel Therapies and Streamline Drug Development
The United States Food and Drug Administration (FDA) has officially rolled out the Rare Disease Framework Initiative, a sweeping regulatory…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape of American pharmaceutical manufacturing is undergoing a seismic shift as the U.S. government implements a aggressive trade policy…
Read More
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Pharmaceutical giant Pfizer has entered into a strategic research collaboration and licensing agreement with Enodia Therapeutics valued at upwards of…
Read More
Johnson and Johnson Raises 2026 Guidance for Sales and Earnings Despite Generic Headwinds and Major Legal and Acquisition Outlays
Johnson & Johnson has officially raised its financial projections for the full year 2026, demonstrating remarkable resilience in the face…
Read More
